论文信息 - Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets - 字舞流文

Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets

J. Wilmott | R. Scolyer | G. Long | M. Batten | T. Ahmed | R. Saw | A. Menzies | M. Carlino | Ping Shang | P. Ferguson | C. Quek | I. Pires da Silva | J. Thompson | T. N. Gide